Pharmaceuticals, GSK will invest in Siena

GlaxoSmithKline, the pharmaceuticals giant that generates approximately 1.5 billion Euros of turnover in Italy, lands in Tuscany, and promises to invest in Siena and the vaccines division.

Port of Livorno moves towards opening to private capital

The port of Livorno wagers on private investors for its relaunch. At the end of the summer, the Port of Livorno Authority, the public office that controls the Tuscan port, will begin its search for a stockholding partner by initiating a tender whose objective is ceding a considerable portion of the capital

fst